A Safety and Effective Study of Ginkgolides Diterpene Lactone Meglumine Injection in the Treatment of Ischemic Stroke.
Enrolling by invitation
Phase 2 Results N/ASummary of Purpose
The aim of this study is to evaluate the safety and effectivity of Ginkgo diterpene lactone meglumine injection tn the treatment of acute ischemic stroke
Read More →Trial Milestones
The following dates are available for this trial. Trial information last updated on 25 February 2016.
1 Jun 2015 | 5 Aug 2015 | 1 Aug 2016 | 1 Feb 2017 | 1 Feb 2016 | Unavailable |
Start Date | First Received | 1st Completion | Completion | Verification | Results |
---|
Trial Basics
Interventions
- Ginkgo diterpene lactone meglumine injection
- Ginkgo diterpene lactone meglumine injection simulation
Conditions
Sponsors
Trial Design
- Allocation: Randomized
- Masking: Double Blind (Subject, Caregiver, Investigator)
- Purpose: Treatment
- Endpoint: Safety/Efficacy Study
- Intervention: Parallel Assignment
Contacts
- yongjun wang, M.D.
13911172565
- yilong wang, M.D.
yilong528@gmail.com 13911666571
View Trial Locations
Recruitment
- Enrollment: 3,452
- Gender: Both
- Minimum Age: 18 Years
- Accepts Healthy Volunteers: No
- 1 location, 1 country
Principal Investigator
- yongjun wang, M.D.
13911172565